Novo Nordisk’s ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the future of the Wegovy obesity drug maker.
Source
Novo Nordisk’s ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the future of the Wegovy obesity drug maker.
Source
People crossing the street in Shibuya, Tokyo. Maydays | Moment | Getty Images Asia-Pacific markets traded mixed Monday as investors assessed ongoing geopolitical concerns. On Sunday stateside, Canadian Prime Minister Mark Carney said that his country has no intention of pursuing a free trade agreement with China, after U.S. President Donald Trump threatened to impose […]
Read More
The global stock market rally may be running on borrowed time after a blistering momentum in 2025, with veterans warning that the odds of a correction are rising as stretched valuations collide with mounting geopolitical and policy risks. Equities entered 2026 on a steady footing after a robust year. The MSCI All Country World Index […]
Read More